Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA

Patel Sanj K sold 508,339 Kiniksa Pharmaceuticals International, Plc shares (Form 4)

Traded Apr 28 to Apr 30, 2026 · Filed Apr 30, 2026

From Apr 28 to Apr 30, 2026, Patel Sanj K (Director, CHAIRMAN & CEO) sold 508,339 Kiniksa Pharmaceuticals International, Plc shares at an average US$51.96 for US$26.4M under a trading plan, leaving 0 shares. Filed Apr 30, 2026 (Form 4).

Sold
508,339 shares
Price
US$51.96 average (US$50.43 to US$54.02)
Value
US$26.4M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CHAIRMAN & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 28, 2026Class A Ordinary ShareOption exercise431,904US$10.36431,904Direct
Apr 28, 2026Class A Ordinary ShareOption exercise51,750US$30.93483,654Direct
Apr 28, 2026Class A Ordinary ShareSale74,635US$50.43409,019Direct
Apr 28, 2026Class A Ordinary ShareSale113,673US$51.47295,346Direct
Apr 28, 2026Class A Ordinary ShareSale243,596US$52.0251,750Direct
Apr 28, 2026Class A Ordinary ShareSale51,750US$54.020Direct
Apr 29, 2026Class A Ordinary ShareOption exercise22,544US$30.9322,544Direct
Apr 29, 2026Class A Ordinary ShareSale22,544US$54.010Direct
Apr 30, 2026Class A Ordinary ShareOption exercise2,141US$30.932,141Direct
Apr 30, 2026Class A Ordinary ShareSale2,141US$54.010Direct

Source

View original at SEC

Related